S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

AXYX

Axonyx (AXYX)

Axonyx

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AXYX

Date	Time	Source	Headline	Symbol	Company
09/28/2006	3:15PM	Business Wire	Axonyx Stockholders Approve Merger with TorreyPines Therapeutics Inc.	NASDAQ:AXYX	Axonyx
09/21/2006	10:00AM	PR Newswire (US)	TorreyPines Therapeutics to Present at the UBS Global Life Sciences Conference	NASDAQ:AXYX	Axonyx
08/30/2006	10:00AM	PR Newswire (US)	TorreyPines Therapeutics to Present at the Thomas Weisel Partners 2006 Healthcare Conference	NASDAQ:AXYX	Axonyx
08/08/2006	7:30AM	Business Wire	AXONYX Inc. Announces Second Quarter 2006 Financial Results	NASDAQ:AXYX	Axonyx
08/07/2006	8:30AM	PR Newswire (US)	TorreyPines Therapeutics Initiates Phase I Clinical Trial of NGX426, a Novel Oral Therapy for Migraine and Neuropathic Pain	NASDAQ:AXYX	Axonyx
08/04/2006	3:30PM	Business Wire	Axonyx Receives Notice Related to Nasdaq Minimum Bid Price Rule	NASDAQ:AXYX	Axonyx
07/24/2006	8:30AM	PR Newswire (US)	TorreyPines Therapeutics Completes Second Phase I Study for NGX267, a Selective M1 Agonist for the Treatment of Alzheimer's Dis	NASDAQ:AXYX	Axonyx
06/20/2006	10:00AM	PR Newswire (US)	TorreyPines Therapeutics to Present at the Jefferies & Company Life Sciences Conference	NASDAQ:AXYX	Axonyx
06/09/2006	10:34AM	PR Newswire (US)	TorreyPines Therapeutics to Present at the 2006 Pacific Growth Equities Life Sciences Growth Conference	NASDAQ:AXYX	Axonyx
06/08/2006	7:00AM	Business Wire	Axonyx and TorreyPines to Host Webcast and Conference Call on Announced Merger	NASDAQ:AXYX	Axonyx
06/08/2006	5:30AM	Business Wire	Axonyx and TorreyPines Therapeutics Announce Merger Agreement; Transaction Creates Robust Portfolio in the CNS Disease Area	NASDAQ:AXYX	Axonyx
05/15/2006	3:15PM	Business Wire	Axonyx Announces Completion of the Multiple-Dose Phase I Study of Posiphen(TM)	NASDAQ:AXYX	Axonyx
05/10/2006	4:30PM	Business Wire	Axonyx Inc. Reports First Quarter 2006 Financial Results	NASDAQ:AXYX	Axonyx
05/09/2006	8:28AM	Business Wire	Axonyx to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference; Presentation to be Web Cast Live on Corporat	NASDAQ:AXYX	Axonyx
04/24/2006	7:30AM	Business Wire	Researcher Reports Data on Effects of Posiphen(TM) on Human Neuronal Stem Cells; Posiphen May Support Stem Cell Transplantation	NASDAQ:AXYX	Axonyx
04/20/2006	3:30PM	Business Wire	Axonyx Reports Data on Effects of Phenserine on the Brains of Alzheimer's Disease Patients; PET Scans Show Increased Brain Neur	NASDAQ:AXYX	Axonyx
04/19/2006	3:30PM	Business Wire	Axonyx Reports Data on Stabilized Brain Volumes in Alzheimer's Disease Patients Treated with Phenserine; Analysis of Brain Scan	NASDAQ:AXYX	Axonyx
03/16/2006	3:15PM	Business Wire	Axonyx Reports Fourth Quarter and Full Year 2005 Financial Results	NASDAQ:AXYX	Axonyx
03/08/2006	3:24PM	Business Wire	Axonyx Regains Compliance with Nasdaq Minimum Bid Price Rule	NASDAQ:AXYX	Axonyx
02/23/2006	7:33AM	Business Wire	Axonyx to Present at the Wall Street Analyst Forum; Presentation to be Web Cast Live on Corporate Web Site	NASDAQ:AXYX	Axonyx
02/14/2006	7:33AM	Business Wire	Axonyx Reports Phenserine Associated with Significant Amyloid Reduction in Phase I Trial; Results Support Dual Mechanisms of Act	NASDAQ:AXYX	Axonyx
02/07/2006	8:00AM	Business Wire	Axonyx to Present at BIO CEO & Investor Conference 2006; Presentation to be Web Cast Live on Corporate Web Site	NASDAQ:AXYX	Axonyx
01/31/2006	7:30AM	Business Wire	Axonyx Announces Acceptance of Four Abstracts Highlighting Phenserine and Posiphen by the 9th International Geneva/Springfield S	NASDAQ:AXYX	Axonyx
01/24/2006	7:30AM	Business Wire	Axonyx Completes First Phase I Trial with Posiphen for Alzheimer's Disease Progression	NASDAQ:AXYX	Axonyx
01/04/2006	7:30AM	Business Wire	Axonyx Announces License of Phenserine to Daewoong Pharmaceutical Company for South Korea	NASDAQ:AXYX	Axonyx
11/09/2005	7:30AM	Business Wire	Axonyx Inc. Announces Third Quarter Financial Results	NASDAQ:AXYX	Axonyx
11/07/2005	3:47PM	Business Wire	Axonyx Provides Update on Clinical Development Program and Strategic Initiatives	NASDAQ:AXYX	Axonyx
10/26/2005	7:00AM	Business Wire	Axonyx to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference; Presentation to Be Web Cast Live on Corporate W	NASDAQ:AXYX	Axonyx
09/20/2005	8:00AM	Business Wire	Axonyx Announces Results of Curtailed Phase III Clinical Trials for Phenserine in Alzheimer's Disease	NASDAQ:AXYX	Axonyx
09/15/2005	7:30AM	Business Wire	Axonyx to Present at the UBS 2005 Global Life Sciences Conference; Presentation to be Web Cast Live on Corporate Web Site	NASDAQ:AXYX	Axonyx

Showing the most relevant articles for your search:NASDAQ:AXYX

Fannie Mae (QB)

Trump Media and Technology

Ronn Motor (PK)

Innovation Pharmaceuticals (CE)

Northwest Biotherapeutics (QB)

Kraig Biocraft Laborator... (QB)

Impact Fusion (PK)

Revance Therapeutics

Anavex Life Sciences

Digital Brand Media and ... (PK)

TPT Global Tech (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions